Vaccine Confidence
Improving vaccine confidence in the most vulnerable populations
Despite the historical triumph of vaccination, societal distrust in the importance, safety, and effectiveness of vaccination has resulted in lowered rates of vaccine confidence amongst populations, contributing to epidemiological shifts in the burden of vaccine preventable diseases (VPDs).
To combat this challenge, the IFA led the expert meeting, ‘Improving vaccine confidence in the most vulnerable populations’ in Brussels, Belgium, gathering leaders of public health and patient advocacy organizations, alongside experts in immunization and health policy to discuss and determine tangible actions to improve vaccination uptake rates in the most vulnerable populations across Europe. Together, there was a commitment amongst all delegates towards key actions to improve vaccine confidence, and, therefore, vaccination uptake rates in the most vulnerable populations across Europe.
Expert meeting:
Improving vaccine confidence in the most vulnerable populations
Consensus statement
International Federation on Ageing
Expert meeting:
Improving vaccine confidence in the most vulnerablepopulations
Executive summary
International Federation on Ageing
Message Bank
The IFA has created the following Good Practices Message Bank to help organizations for older adults share impactful information to their members.
Caption:
Health promotion includes vaccination! Ensuring that vaccines are in the narrative of healthy ageing was a key takeaway from the IFA expert meeting held in July 2022, which brought together public health leaders to improve #VaccineConfidence.
Read it here: https://bit.ly/3hG4jCG
#IFA #V4L #HealthyAgeing
Caption:
Health promotion includes vaccination! Ensuring that vaccines are in the narrative of healthy ageing was a key takeaway from the IFA expert meeting held in July 2022, which brought together public health leaders to improve #VaccineConfidence.
Read it here: https://bit.ly/3hG4jCG
#IFA #V4L #HealthyAgeing
Pneumococcal disease is a leading cause of hospitalization and mortality in Canada. There is a high prevalence of this disease amongst populations that are most at-risk of serious complications from infection, such as older adults in long-term care settings.
The ‘Driving the agenda of pneumococcal pneumonia vaccination in at-risk populations in community and long-term care’ study was conducted to understand the status of existing public health policies and campaigns on pneumococcal disease in community and long-term care settings and its implications on the uptake of pneumococcal vaccination. The report highlights policy gaps for pneumococcal vaccination across long-term care settings in Canada and accordingly provides recommendations for policy improvements.
Pneumococcal disease is a leading cause of hospitalization and mortality in Canada. There is a high prevalence of this disease amongst populations that are most at-risk of serious complications from infection, such as older adults in long-term care settings. Check out the technical report to learn more.
27 April 2023, Toronto, ON – The International Federation on Ageing (IFA) is proud to release findings from a recent study entitled Driving the agenda of pneumococcal pneumonia vaccination in at-risk populations in community and long-term care. Check out the technical report to learn more.
IFA acknowledges support from GSK and Sanofi Pasteur for Vaccines4Life through unrestricted educational grants and is proud to be part of the Vaccines Safety Net (VSN) Database.
Contact us
Telephone: +1 (416) 342-1655
Fax: +1 (416) 639-2165
1 Bridgepoint Drive, Suite G.238
Toronto, Ontario
Canada
M4M2B5
© 2025 International Federation on Ageing. All rights reserved.
Website design by:
